Knuff & Co LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 13,038 shares of the company’s stock, valued at approximately $1,675,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Comprehensive Financial Planning Inc. PA bought a new position in shares of Merck KGaA in the second quarter valued at $134,000. Stevens Capital Partners acquired a new position in Merck KGaA during the second quarter worth $220,000. BOK Financial Private Wealth Inc. bought a new stake in Merck KGaA during the second quarter worth $523,000. Compass Wealth Management LLC bought a new stake in Merck KGaA during the second quarter worth $834,000. Finally, Chancellor Financial Group WB LP acquired a new stake in Merck KGaA in the second quarter valued at $839,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of MKGAF opened at $167.38 on Thursday. The company has a market cap of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. The firm has a 50-day moving average of $162.50 and a 200-day moving average of $148.28. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
